Speech-Language Pathologists in Weare, NH Accepting Medicare
7 Speech-Language Pathologists found. Showing 1 - 7
 Judith Attorri Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 14 Center Road, Weare, NH 03281 Phone: 603-529-4500 |
Darlene Kathryn Ferroli, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 21 Pine Hill Est, Weare, NH 03281 Phone: 603-529-3568 |
Erin Leigh Aylward Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 16 East Rd, Weare, NH 03281 Phone: 603-529-7555 Fax: 603-529-0464 |
Heather Marshall Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 14 Center Rd, Weare, NH 03281 Phone: 603-529-4500 |
Cheyenne Mae Ferno Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 14 Center Rd, Weare, NH 03281 Phone: 603-863-1681 |
 Mr. Michael Alan Craig, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 220 Barnard Hill Rd, Weare, NH 03281 Phone: 603-313-3985 |
Mrs. Danielle Anita Bond-ishak, MS, CCC, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 203 Concord Stage Rd, Weare, NH 03281 Phone: 603-529-0926 |
News Archive
Study assesses risk of GBS following H1N1 vaccine administration
Guillain-Barre syndrome (GBS) is usually characterized by rapidly developing motor weakness and areflexia (the absence of reflexes). "The disease is thought to be autoimmune and triggered by a stimulus of external origin. In 1976-1977, an unusually high rate of GBS was identified in the United States following the administration of inactivated 'swine' influenza A(H1N1) vaccines.
Oxygen Biotherapeutics announces CRADA Agreement amendment
Oxygen Biotherapeutics, Inc. today announced it has amended an existing Cooperative Research and Development Agreement (CRADA) with the U.S. Naval Medical Research Center (NMRC) to include preclinical trials using swine models to assess the safety and efficacy of Oxygen Biotherapeutics' proprietary Oxycyte perfluorocarbon emulsion (PFCE) for spinal cord injury (SCI) due to decompression sickness (DCS), and for hemorrhagic shock.
Obama visits House Republicans, points out willingness to make some changes to Medicare
Lawmakers who attended the closed-door meeting said he focused on changes in how cost-of-living increases are calculated, but press reports indicate that partisan differences remain deep.
PositiveID and RFID Solutions complete development of temperature-sensing microchip
PositiveID Corporation announced today that it has completed the development of its temperature-sensing microchip in conjunction with development partner RFID Solutions of Malaga, Spain. The microchip, which uses radio frequency identification (RFID) technology, is able to measure internal temperature within the body and communicate that temperature wirelessly to an external reader.
Tizard Centre to support Autism London to provide better understanding of hate crimes
The Tizard Centre at the University of Kent will support Autism London on a major new project that aims to provide a better understanding of hate crimes and victimisation against people with autism and learning disabilities.
› Verified 9 days ago